IS LOW DOSE ASPIRIN EFFECTIVE IN REDUCING IN-HOSPITAL CLINICAL OUTCOMES IN PATIENTS WITH COVID-19?

Podobne zapisy

• Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population
  od: Gurbel, Paul A., i wsp.
  Wydane: (2021)
• IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
  od: Gurbel, Paul A., i wsp.
  Wydane: (2021)
• AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
  od: Gurbel, Paul A., i wsp.
  Wydane: (2021)
• High-Dose, but Not Low-Dose, Aspirin Impairs Anticontractile Effect of Ticagrelor following ADP Stimulation in Rat Tail Artery Smooth Muscle Cells
  od: Grześk, Grzegorz, i wsp.
  Wydane: (2013)
• First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19
  od: Tantry, Udaya S, i wsp.
  Wydane: (2021)